Cargando…
Serum neurofilament light chain is increased in hereditary spastic paraplegias
Blood biomarkers are still largely missing in hereditary spastic paraplegias (HSPs). We here explored Neurofilament light chain (NfL) as a biomarker in HSP. Serum NfL was assessed in 96 HSP (63 genetically confirmed), 96 healthy control, and 33 ALS subjects by single molecule array (Simoa). Compared...
Autores principales: | Wilke, Carlo, Rattay, Tim W., Hengel, Holger, Zimmermann, Milan, Brockmann, Kathrin, Schöls, Ludger, Kuhle, Jens, Schüle, Rebecca, Synofzik, Matthis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043776/ https://www.ncbi.nlm.nih.gov/pubmed/30009206 http://dx.doi.org/10.1002/acn3.583 |
Ejemplares similares
-
Characteristics of serum neurofilament light chain as a biomarker in hereditary spastic paraplegia type 4
por: Kessler, Christoph, et al.
Publicado: (2022) -
Neurofilament light chain is a cerebrospinal fluid biomarker in hereditary spastic paraplegia
por: Kessler, Christoph, et al.
Publicado: (2021) -
Serum Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Biomarkers in Primary Progressive Multiple Sclerosis and Hereditary Spastic Paraplegia Type 4
por: Kessler, Christoph, et al.
Publicado: (2022) -
Abnormal Paraplegin Expression in Swollen Neurites, τ- and α-Synuclein Pathology in a Case of Hereditary Spastic Paraplegia SPG7 with an Ala510Val Mutation
por: Thal, Dietmar R., et al.
Publicado: (2015) -
AP5Z1/SPG48 frequency in autosomal recessive and sporadic spastic paraplegia
por: Schlipf, Nina A, et al.
Publicado: (2014)